Lazcluze
RxNorm concept 2691157, brand name (bn).
- RxCUI
- 2691157
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2691157 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- lazertinib 80 MG [Lazcluze] (SBDC, ingredient of)
- Lazcluze Oral Product (SBDG, ingredient of)
- Lazcluze Pill (SBDG, ingredient of)
- lazertinib Oral Tablet [Lazcluze] (SBDF, ingredient of)
- lazertinib 80 MG Oral Tablet [Lazcluze] (SBD, ingredient of)
- lazertinib 240 MG [Lazcluze] (SBDC, ingredient of)
- lazertinib 240 MG Oral Tablet [Lazcluze] (SBD, ingredient of)
- lazertinib (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2691157 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2691157 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2691157. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.